BioCentury
ARTICLE | Clinical News

Alnylam preclinical data

October 28, 2013 7:00 AM UTC

In a mouse model of acute intermittent porphyria, ALN-AS1 rapidly and dose-dependently reduced aminolevulinate synthase-1 (ALAS-1) mRNA and led to complete inhibition of the toxic heme biosynthesis i...